Friday, August 21, 2026
GlobeNewsInfo Logo
Home / Business & Corporate / Formic secures $50 million Series B funding to expand physical AI robotics platform across US manufacturing

Formic secures $50 million Series B funding to expand physical AI robotics platform across US manufacturing

Published on
Formic secures $50 million Series B funding to expand physical AI robotics platform across US manufacturing
Image used for illustrative purposes only. GlobeNewsInfo / Visuals

Formic has secured $50 million in Series B growth capital to advance its physical artificial intelligence and robotics commercialization platform. Led by Mercato Partners, the funding will support the transition from task-specific automation to general-purpose robotics, enabling domestic manufacturers to scale production without significant upfront capital expenditures.

UNITED STATES OF AMERICA —Formic has secured $50 million in Series B growth capital to advance its physical artificial intelligence and robotics commercialization platform. The financing round was led by Mercato Partners, with participation from Light Ray Ventures, Lightscape Partners, Citi, and debt financing provided by S2G Investments. The capital injection is designated to accelerate the enterprise's transition from task-specific automation toward general-purpose robotics, strengthening its underlying software and operational capabilities.

This development matters because it addresses a persistent bottleneck in industrial automation: the gap between theoretical robotic capabilities and practical, productive deployment in real-world factory environments. By evolving its platform to support general-purpose robotics, the organization can apply operational intelligence gathered across multiple sites to optimize increasingly complex tasks. This shift primarily impacts mid-market manufacturers in the United States, allowing them to integrate advanced automation without assuming the traditional balance sheet risks associated with purchasing and integrating proprietary hardware.

The broader manufacturing sector is currently navigating intense pressure to reshore production and expand domestic capacity, particularly in strategic industries such as aerospace, defense, medical devices, and energy. Regulatory and economic incentives are increasingly favoring localized supply chains, yet small and medium-sized enterprises often lack the capital to execute traditional automation projects. By deploying a Robots-as-a-Service model, this platform removes upfront capital expenditure barriers, enabling a wider swath of the industrial base to modernize operations and increase output resilience.

For Formic, a Chicago-based enterprise founded in 2020 that combines robotic equipment, deployment software, field operations, and production data into a unified service, this funding supports expansion into new verticals like metal fabrication. The strategy leverages continuous data collection to refine artificial intelligence models, creating a compounding network effect where each deployment improves the overall system's efficiency. Investors are betting on a scalable commercialization engine that can standardize physical artificial intelligence across diverse manufacturing environments, positioning the company as a critical infrastructure provider for the modernized United States industrial base.

About GlobeNewsInfo

GlobeNewsInfo is a business news platform providing latest updates on global business developments, projects, and contract opportunities across diverse sectors and regions. The platform is designed to serve as a trusted source of information for companies, investors, and professionals worldwide.

More on Business & Corporate

Latest Business News

Share this Article

Just In
1 hour ago Ovzon secures additional NATO terminal order worth SEK 39 million 1 hour ago Eli Lilly breaks ground on $5 billion pharmaceutical manufacturing facility in Virginia 1 hour ago Sentinel Exploration commences maiden aircore drilling program at Menzies West Gold Project in Western Australia 1 hour ago Gilead Sciences enters definitive agreement to acquire PepStar Therapeutics oral immunology program for 1.275 billion dollars